How "malignant" is the neuroleptic malignant syndrome?
- 13 November 1993
- Vol. 307 (6914) , 1223-1224
- https://doi.org/10.1136/bmj.307.6914.1223
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The role of creatine kinase in the diagnosis of Neuroleptic Malignant SyndromePsychological Medicine, 1993
- Catatonia and the Neuroleptic Malignant Syndrome – a Single Entity?The British Journal of Psychiatry, 1992
- A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndromeMedical Hypotheses, 1992
- Sympathoadrenomedullary activity in the neuroleptic malignant syndromeBiological Psychiatry, 1992
- Neuroleptic Toxicity Syndromes: A Clinical SpectrumAustralian & New Zealand Journal of Psychiatry, 1991
- The Myth of Elevated Serum Creatine Phosphokinase Level and Neuroleptic Malignant SyndromeThe British Journal of Psychiatry, 1991
- CPK in NMSThe British Journal of Psychiatry, 1991
- Neuroleptic malignant syndrome: A study of CSF monoamine metabolismBiological Psychiatry, 1990
- Neuroleptic malignant syndrome. Review of response to therapyArchives of internal medicine (1960), 1989
- The Neuroleptic Malignant Syndrome, So-calledThe British Journal of Psychiatry, 1987